oral glp-1 medications approved US FDA accepts Novo Nordisk's application for Wegovy for weight loss Wegovy Pill Becomes First Oral

Even customers who prefer to shop in person often want reassurance before they leave home

Fisher explains why drug companies have shifted their focus from diabetes treatment to weight loss

Common adverse effects include nausea, vomiting, diarrhoea, injection site reactions, and increased heart rate, particularly during dose escalation

Notice the pattern: 20mg/mL concentrations (from 20mg/1mL, 30mg/1.5mL configurations) keep every dose from 1mg through 12mg within a single syringe draw

Slow titration with 4-week holds between increases allows GI adaptation and significantly reduces the severity of each wave

Thats very hard to break. Most patients notice their first slowdown of weight loss somewhere around months four to six, as the body begins adapting